Welcome to our dedicated page for Xebra Brands news (Ticker: XBRAF), a resource for investors and traders seeking the latest updates and insights on Xebra Brands stock.
Xebra Brands Ltd. (XBRAF) generates frequent corporate and regulatory updates that are relevant for investors following cannabis and wellness companies. Its news flow covers both operational developments and capital markets events across its activities in Mexico, Canada and the United States.
In its releases, Xebra reports on the development and commercialization of cannabis‑derived wellness products, including its ELEMENTS™ CBD product line and Vicious Citrus THC/CBN lemonades. News items have described progress toward the U.S. launch of ELEMENTS™, such as finalized product formulations, packaging and e‑commerce planning, as well as integration into logistics and fulfillment infrastructure.
The company’s disclosures also address regulatory milestones and authorizations. Xebra highlights its authorization from COFEPRIS in Mexico to import, cultivate, manufacture and sell cannabis with less than 1% THC, and provides updates on how this supports its international cannabis cultivation and product strategy.
From a capital markets perspective, Xebra’s news includes information on management changes, loan agreements with existing shareholders, warrant expiry extensions, and share consolidation plans on a ten‑for‑one basis. The company has also issued detailed updates on its management cease trade order and subsequent failure‑to‑file cease trade order related to delayed financial statement filings, as well as the impact on trading of its securities on the Canadian Securities Exchange and its move from the OTCQB Market to the OTC Pink Open Market.
Readers of the XBRAF news page can expect coverage of product commercialization efforts, regulatory authorizations, financing and corporate structure changes, and filing status reports. Monitoring these releases can help track how Xebra manages its cannabis‑derived product portfolio, regulatory relationships and listing status over time.
Xebra Brands (XBRA:CSE)(XBRAF:OTCQB) has entered into a non-binding letter of intent to acquire BSK Holdings Inc., a CBD e-commerce company, expected to complete by Q3 2025. BSK has generated over $50M USD in revenue since 2021, with $2.1M in EBIDTA and 62% gross margin.
The acquisition represents approximately 45% of Xebra's share capital, valued at $4.5MM CAD. BSK brings established brands like Keoni and AMMA, along with expertise in scaling cannabis and hemp companies. The deal aims to strengthen Xebra's position in the North American CBD market, particularly in the US and Mexico.
Key transaction highlights include:
- Creation of a strategic platform for North American growth
- Enhanced Mexican CBD market penetration
- Expanded product portfolio combining BSK's brands with Xebra's Elements line
- Development of e-commerce capabilities for the Mexican market
Xebra Brands (CSE:XBRA)(OTCQB:XBRAF) has signed a Manufacturing and Distribution Agreement with NF Skin and its fulfillment division, RT Fulfillment, dated April 14, 2025. The partnership aims to launch Xebra's ELEMENTS™ CBD product line in the U.S. market.
NF Skin, established in 2003, will provide custom formulation, manufacturing, packaging, and branding services in GMP-certified U.S. facilities. The ELEMENTS™ product line will include tinctures, topicals, gummies, and wellness supplements. RT Fulfillment will manage drop shipping, inventory, and order fulfillment operations.
This collaboration supports Xebra's strategy to expand its presence in the U.S. CBD market and diversify operations across North America.
Xebra Brands (CSE:XBRA)(OTCQB:XBRAF), the only company legally authorized to cultivate and sell cannabis (-1% THC) in Mexico, has announced a Request for Proposal (RFP) initiative to establish 5-12 agricultural partnerships across Mexico for cannabis cultivation under federal authorization.
The RFP will be open from June 1, 2025 to August 31, 2025, with selected partners to be announced in fall 2025. The company is seeking experienced agricultural companies, landowners, and municipal entities for these partnerships.
The RFP evaluation criteria includes:
- Land information and infrastructure suitability
- Legal compliance with COFEPRIS guidelines
- Operational experience in high-value crop cultivation
- Business model and investment proposals
- Environmental sustainability practices
- Security protocols
- Implementation readiness
Xebra Brands (XBRAF) has reinforced its North American market strategy following recent U.S. tariff announcements. The company, which holds exclusive authorization to operate in Mexico's cannabis sector, benefits from the USMCA exemption from the new 10% universal U.S. import tariff announced on April 2, 2025.
The company is pursuing two significant initiatives: a landmark agricultural agreement with major shareholder David Ross Macias Diaz for cannabis cultivation in Mexico, and a strategic partnership with BSK to enhance e-commerce presence and facilitate U.S. market entry for its Elements™ product line.
Interim-CEO Rodrigo Gallardo emphasized that recent market developments reinforce their North American strategy, particularly given the protected trade environment under USMCA.
Xebra Brands (CSE:XBRA)(OTCQB:XBRAF)(FSE:9YC0), the only company with federal authorization to operate in Mexico's cannabis sector, announces two significant developments. First, its largest shareholder, David Ross Macias Diaz, has increased his stake by purchasing 1,000,000 common shares, bringing his total holding to 13,591,333 shares.
Additionally, Xebra is exploring a strategic agricultural agreement with Mr. Diaz to utilize his land in Mexico for cannabis cultivation under the company's federal authorization. This would mark the first economic agricultural agreement in Mexico executed under a Federal cannabis authorization. As the only company approved by COFEPRIS for legal cannabis operations (-1% THC), Xebra aims to establish a scalable blueprint for future cultivation partnerships.
Xebra Brands (CSE:XBRA)(OTCQB:XBRAF) and BSK Holdings Inc. have expanded their partnership to launch Elements CBD products in the United States market. BSK will leverage its proven track record in building CBD brands that generated over $100M in revenue over the past 5 years.
The expansion targets the U.S. CBD market, which exceeded $5 billion in 2024 and is projected to grow at a 15% CAGR through 2030. BSK will assist Xebra with:
- Product development and SKU selection
- Manufacturing and distribution partnerships
- Market entry strategy
- E-commerce direct-to-consumer website development
BSK plans to position Elements in both wellness and active lifestyle verticals, leveraging their established network, digital marketing expertise, and subscription-based sales infrastructure. This expansion complements Xebra's existing leadership in the Mexican cannabis market, where they hold exclusive commercialization rights for cannabis (-1% THC).
Xebra Brands (CSE:XBRA)(OTCQB:XBRAF)(FSE:9YC0) announces strategic initiatives following the receipt of a Dutch cannabis cultivation license for scientific research on June 13, 2024. The license, numbered 109230 CO/w, was issued by the Minister of Health, Welfare and Sport, allowing the company's subsidiary Xebra Brands Europe B.V. to legally cultivate and process cannabis for scientific purposes at their R&D facility in Wilp, Gelderland.
The company, which holds exclusive rights to cultivate and sell cannabis (-1% THC) in Mexico, is exploring several business opportunities including:
- Cannabis genetics R&D and proprietary cultivar development
- Strategic partnerships with European entities
- Product innovation for European markets
- Export opportunities within EU
- Contract manufacturing services
- Scientific research collaborations
- Potential B2B sales to licensed retailers
Xebra Brands (CSE:XBRA)(OTCQB:XBRAF)(FSE:9YC0) has announced a strategic partnership with BSK Holdings Inc. to launch Elements branded CBD products in the Mexican market through e-commerce platforms. As the only company legally permitted to operate in Mexico's cannabis sector (-1% THC), Xebra aims to leverage BSK's expertise in the CBD and hemp markets.
BSK's team has previously built successful brands like Manitoba Harvest (acquired for $400M+ by TILRAY) and has generated over $100M in revenue across their brands in the last 5 years. The partnership targets Mexico's rapidly growing e-commerce market, which reached USD 26.2 billion in 2022, showing a 23% year-over-year increase. In 2024, Mexico's e-commerce market has approximately 74 million users and generated around $38 billion, with forecasts suggesting these figures will double within five years.
Xebra Brands (XBRAF) welcomes a significant announcement from Mexico's COFEPRIS (Federal Commission for Protection against Sanitary Risks) that condemns illegal marketing of unregulated CBD and cannabis-derived products in Mexico. The regulatory body has explicitly named several unauthorized brands, warning consumers of potential health risks.
As the only company with fully authorized federal permits for legal cannabis commercialization in Mexico, Xebra stands to benefit from this regulatory crackdown. The company has initiated discussions with affected brands to explore potential pathways for legal operation under Xebra's federal authorizations.
CEO Rodrigo Gallardo describes this as a 'game-changer' for Mexico's cannabis industry, indicating a clear shift toward a fully regulated market. The company aims to help legitimate businesses transition into Mexico's formal cannabis sector while ensuring consumer safety and regulatory compliance.
Xebra Brands (XBRAF) has unveiled its Strategic 2025 Roadmap to expand in the North American CBD market. The plan focuses on three key pillars: Domestic CBD Cultivation, CBD Manufacturing, and Rapid Retail Distribution.
As the first Mexican company with COFEPRIS authorization, Xebra is pursuing expanded cultivation licenses and partnerships. The company is collaborating with Chapingo University for cultivation research and has received approval for two CBD products developed with Restorative Botanicals, including a 250mg Tangerine Flavor CBD Tincture.
The company expects to complete product importation by April 2025 and is establishing e-commerce operations in Mexico through a partnership with ICAN. The North American CBD market, valued at USD 6.7 billion in 2023, is projected to grow at a 14.2% CAGR from 2024 to 2030.